alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               SEP-30-2000             SEP-30-1999
<CASH>                                      18,966,253               7,710,403
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                            19,669,379               7,728,251
<PP&E>                                         279,775                 195,048
<DEPRECIATION>                                 145,560                  94,635
<TOTAL-ASSETS>                              19,803,594               7,828,664
<CURRENT-LIABILITIES>                        6,450,113               1,462,450
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                       27,617,105                       0
<PREFERRED>                                      6,402                   6,402
<COMMON>                                         5,948                   5,844
<OTHER-SE>                                (14,275,974)               6,353,968
<TOTAL-LIABILITY-AND-EQUITY>                19,803,594               7,828,664
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                               18,136,413               7,117,626
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                 586,140
<INCOME-PRETAX>                           (17,596,364)             (7,560,915)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                       (17,596,364)             (7,560,915)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                              (17,596,364)             (7,560,915)
<EPS-BASIC>                                     (7.87)                  (1.29)
<EPS-DILUTED>                                   (7.87)                  (1.29)


</TABLE>
Exhibit 10.70



AMENDMENT OF

EMPLOYMENT LETTER AGREEMENT



This instrument amends
the employment letter agreement dated October 16, 2002 between Path 1 Network Technologies Inc. and John R. Zavoli.



The Severance Agreement item therein is amended to read in full as follows:



Severance Agreement: Twelve months severance in the form of salary and benefit continuation in case of
termination by Path 1 for any reason other than cause. Subject to this severance arrangement, you shall be an at-will employee and your employment can be terminated at any time by Path 1, or by you, for any reason or for no reason.



Dated: May 11, 2004

PATH 1 NETWORK TECHNOLOGIES INC.By:

/S/    JOHN ZAVOLI(Upon authority of the Compensation Committee, by
action taken May 10, 2004)/S/    JOHN ZAVOLIJOHN R. ZAVOLI
<PAGE>   1

                                                                   EXHIBIT 10(W)

                           VARSITY SPIRIT CORPORATION
                            2525 Horizon Lake Drive
                               Memphis, TN 38133
                             Memphis, TN 38184-1609
                                  901-387-4370
                               Fax: 901-387-4356

June 4, 1996

Kraig Tallman
2525 Horizon Lake Drive
Memphis, TN 38133

RE: Extension of Employment Agreement

Dear Kraig:

     This is to confirm the extension of the term of the Employment Agreement,
dated as of September 29, 1989, by and between you and Varsity Spirit
Corporation. Section 1 of the Employment Agreement is hereby amended to provide
as follows:

     1. Employment. The Company agrees to employ Executive and Executive accepts
such employment for the initial period beginning as of the date hereof
(September 29, 1989) and ending on September 28, 1997, subject to possible
earlier termination pursuant to paragraph 1(d) hereof (the "Employment Period").

     Please indicate your agreement with the amendment set forth above by
executing this extension agreement in the space provided below and returning an
executed copy of this agreement to the undersigned.
Very truly yours,

/s/ Jeffrey G. Webb

Jeffrey G. Webb
President
Varsity Spirit Corporation

Accepted and agreed to this 4th day of June, 1996

[NAME OF EMPLOYEE]

/s/ Kraig Tallman
-------------------
(Signature)
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

November 19, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-2687

Price Pump Company:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
---

Exhibit 32.1




CERTIFICATION OF CHIEF EXECUTIVE
OFFICER


PURSUANT TO


18 U.S.C. SECTION
1350,


AS ADOPTED PURSUANT
TO


SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002




I, John
E. Bourgoin, certify, that to my knowledge, the Quarterly Report on
Form 10-Q of MIPS Technologies, Inc. for the quarter
ended December 31, 2008 (the “Form 10-Q”), to which
this certificate is an exhibit fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended,
and that information contained in the Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of MIPS
Technologies, Inc. for the three month period covered by the
Form 10-Q.




Date: February
      6, 2009
            By:
            /s/ JOHN E.
      BOURGOIN
              John E.
      Bourgoin
              President and Chief Executive
      Officer,
              MIPS Technologies,
      Inc.


































A signed original of this written statement required by
Section 906 has been provided by MIPS Technologies and will be retained by
it and furnished to the Securities Exchange Commission or its staff upon
request.
#### J. C. EPTING, JR., by his Next Friend, J. C. Epting, Sr. v. L. R. STEWART, G. A. STEWART, and C. A. FERREE, t/a R. K. STEWART & SON.

(Filed 27 November, 1957)

Automobiles § 24—

In this action to recover for injuries sustained when plaintiff pedestrian ran into the end of a steel beam protruding from a truck which had been parked on the school grounds for five to ten minutes, non-suit was properly allowed.

Appeal by plaintiff from *Rousseau, J.,*May Civil Term 1957 of Guilford (High Point Division).

This is a civil action to recover damages for an injury sustained by plaintiff allegedly resulting from the negligence of defendant.

The plaintiff minor, an eleven-year-old student in Oakview School near High Point, Guilford County, North Carolina, about 2:00 p.m. on 15 October 1955, was returning from a playground area, a part of the school grounds, to the school building, when he ran into the end of steel beam lying across the bed of a pickup truck which was parked adjacent to a school building addition then under construction. The steel beam, commonly called an “I” beam, was painted a bright red. This beam had been moved on the truck from a place on the school grounds where it had been stored with other building materials. The truck had been parked near the building under construction from five to ten minutes before the accident occurred.

At the close of plaintiff’s evidence, defendant moved for judgment as of nonsuit. Motion allowed. Plaintiff appeals, assigning error.

*Morgan, Byerly & Post for plaintiff appellant.*

*Smith, Moore, Smith, Schell & Hunter for defendant appellee.*

Per Curiam.

A review of all the evidence introduced by the plaintiff in the light most favorable to him, in our opinion, is *269insufficient to carry the case to the jury and support a verdict in his favor.

The ruling of the court below will be upheld.

Affirmed.
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3738 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 3738

To direct the Secretary of the Interior to reissue final rules relating 
 to listing the gray wolf in the Western Great Lakes and Wyoming under 
                  the Endangered Species Act of 1973.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 2, 2022

Mr. Johnson (for himself, Mr. Barrasso, and Ms. Lummis) introduced the 
 following bill; which was read twice and referred to the Committee on 
                      Environment and Public Works

_______________________________________________________________________

                                 A BILL

 
To direct the Secretary of the Interior to reissue final rules relating 
 to listing the gray wolf in the Western Great Lakes and Wyoming under 
                  the Endangered Species Act of 1973.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REISSUANCE OF FINAL RULE REGARDING GRAY WOLVES IN WESTERN 
              GREAT LAKES.

    Before the end of the 60-day period beginning on the date of 
enactment of this Act, the Secretary of the Interior shall reissue the 
final rule published on December 28, 2011 (76 Fed. Reg. 81666), without 
regard to any other provision of statute or regulation that applies to 
issuance of such rule. Such reissuance shall not be subject to judicial 
review.

SEC. 2. REISSUANCE OF FINAL RULE REGARDING GRAY WOLVES IN WYOMING.

    The final rule published on September 10, 2012 (77 Fed. Reg. 
55530), that was reinstated on March 3, 2017, by the decision of the 
U.S. Court of Appeals for the District of Columbia (No. 14-5300) and 
further republished on May 1, 2017 (82 Fed. Reg. 20284-85), that 
reinstates the removal of Federal protections for the gray wolf in 
Wyoming under the Endangered Species Act of 1973, as amended, shall not 
be subject to judicial review.
                                 <all>
```
II 

117TH CONGRESS 

2D SESSION S. 4152 

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the 

Critical Path Public-Private Partnerships. 

IN THE SENATE OF THE UNITED STATES 

MAY 5, 2022 

Mr. KELLY (for himself, Ms. COLLINS, and Ms. SINEMA) introduced the following bill; which was read twice and referred to the Committee on 

Health, Education, Labor, and Pensions 

A BILL 

To amend the Federal Food, Drug, and Cosmetic Act to 

reauthorize the Critical Path Public-Private Partnerships. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. REAUTHORIZATION OF THE CRITICAL PATH 

4 PUBLIC-PRIVATE PARTNERSHIPS. 

5 Section 566(f) of the Federal Food, Drug, and Cos6 metic Act (21 U.S.C. 360bbb–5(f)) is amended by striking 

7 ‘‘$6,000,000 for each of fiscal years 2018 through 2022’’ 

8 and inserting ‘‘$10,000,000 for each of fiscal years 2023 

9 through 2027’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
Exhibit No. 23.1
                                                               ----------------






                      CONSENT OF INDEPENDENT ACCOUNTANTS
                      ----------------------------------




We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (File Nos. 333-44868, 33-47407, 33-48500, 33-48501,
333-64643 and 33-67288) of United Retail Group, Inc. and Subsidiaries (the
"Company") of our report dated February 14, 2003, relating to the financial
statements, which appear in this Form 10-K. We also consent to the reference to
us under the heading "Selected Financial Data" which appears in this Form 10-K.



/s/ PricewaterhouseCoopers LLP
------------------------------
New York, New York
March 21, 2003
### THE THIRTEENTH COURT OF APPEALS

13

- 22

- 00062

- CV
In the Interest of D.D.L., a child
On Appeal from the 117th District Court of Nueces County , Texas Trial Court Cause No. 2017

- FAM

- 5048

- B

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this cause on appeal, concludes the judgment of the trial court should be reversed and rendered . The Court orders the judgment of the trial court REVERSED and RENDERS judgment in accordance with its opinion . Costs of the appeal are adjudged against appell ee

. W e further order this decision certified below for observance. August 25 , 2022
---

Exhibit 32.2




CERTIFICATION OF CHIEF FINANCIAL OFFICER


PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




I, Maury Austin, certify, that to my knowledge, the Quarterly Report on Form 10-Q of MIPS Technologies, Inc. for the three months ended September 30, 2009 (the “Form 10-Q”), to which this certificate is an exhibit fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of MIPS Technologies, Inc. for the three month period covered by the Form 10-Q.




Date: November 6, 2009
By:
/s/ MAURY AUSTIN
Maury Austin
Vice President and Chief Financial Officer,
MIPS Technologies, Inc












A signed original of this written statement required by Section 906 has been provided by MIPS Technologies and will be retained by it and furnished to the Securities Exchange Commission or its staff upon request.


---
EXHIBIT 23.1

CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference in Registration Statement Nos. 33-94026, 33-51234, 33-75028, 33-77684, 33-57628,
33-80581, 33-80583, 333-42775, 333-89325, 333-89329, 333-89327 and 333-114694 on Form S-8 of
our report dated March 16, 2006, relating to the financial statements
and financial statement schedule of Apria Healthcare Group Inc. and managements
report of the effectiveness of internal control over financial reporting, appearing in this
Annual Report on Form 10-K of Apria Healthcare Group Inc. for the year ended December 31, 2005.

DELOITTE & TOUCHE LLP

Costa Mesa, California
March 16, 2006
<PAGE>

                                                                EXHIBIT 23.1

                                  CONSENT


We have issued our reports dated February 14, 1997 accompanying the financial 
statements and schedule of Daw Technologies, Inc., incorporated by reference 
or included in the Annual Report of Daw Technologies, Inc., on Form 10-K for 
the year ended December 31, 1996.  We hereby consent to the incorporation by 
reference of said reports in the Registration Statements of Daw Technologies, 
Inc., on Forms S-3 (File No. 33-73292 effective January 3, 1994, File No. 
33-84224 effective March 20, 1995, File No. 33-93656 effective June 30, 1995 
and file No. 333-05541 effective July 15, 1996) and on Forms S-8 (File No. 
33-93206 effective June 7, 1995 and File No. 333-03930 effective April 23, 
1996).

                                           GRANT THORNTON LLP

Salt Lake City, Utah
March 24, 1997
Exhibit 32.2

CERTIFICATION OF CHIEF
FINANCIAL OFFICER 
PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I,
Mervin S. Kato, certify, that to my knowledge,  the Quarterly Report on Form 10-Q
of MIPS Technologies,  Inc. for the three months ended  December 31, 2005 (the "Form 10-Q"),
to which this  certificate  is an exhibit fully  complies with the  requirements  of
Section 13(a)  of the  Securities  Exchange Act of 1934,  as amended, and that information
contained  in the  Form 10-Q  fairly  presents,  in all  material  respects,  the  financial
condition  and  results of operations of MIPS Technologies, Inc. for the three month period
covered by the Form 10-Q.

|                         |                                           
|------------------------ | ------------------------------------------
|                         |                                           
|                         |                                           
|                        
|Dated:  February 8, 2006 | By:     /s/ MERVIN S. KATO                
|                         | Mervin S. Kato                            
|                         | Vice President and Chief Financial Officer
|                         | MIPS Technologies, Inc.                   

A signed original of this written
statement required by Section 906 has been provided by MIPS Technologies and will be
retained by it and furnished to the Securities Exchange Commission or its staff upon
request.

1

---
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

October 18, 2018

RE: Product Exclusion Request Number: USTR-2018-0025-1705

CMT Group LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn
**Exhibit
10.9**
 **OPTION
AGREEMENT**
 
 
 This
Option Agreement evidences the grant of a stock option (the "Option") to
purchase shares of common stock, par value $.001 (the "Company Stock"), of
Generex Biotechnology Corporation (the "Company") granted to **Mark
Fletcher** (the
"Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option
Plan (the “Plan”), a copy of which is attached to this Option Agreement and
incorporated into this Option Agreement by reference. The Option is subject to
the terms, conditions, limitations and restrictions set forth in the Plan,
including the following:
 
 a.  The date
of grant of the Option is **December
13, 2004** and the
number of shares of Company Stock that may be purchased upon exercise of the
Option is **250,000
(Two Hundred Fifty Thousand Dollars)** .
 
 b.  The
purchase price (the “Exercise Price”) of Company Stock subject to the Option is
 **$0.61** per
share.
 
 c.  The
Option is fully vested upon issuance.
 
 d.  Unless
sooner terminated pursuant to the Plan, the Option shall terminate on **December
13, 2009.** Option
will survive the termination of the Optionee’s employment.
 
 e.  The
Optionee shall pay the Exercise Price for the Option (i) in cash or (ii) by such
other method as may be approved by the Compensation Committee of the Company’s
Board of Directors. The Optionee shall pay the amount of any withholding tax due
at the time of exercise, as provided in the Plan.
 
 f.  The
rights and interests of the Optionee under this Option Agreement may not be
sold, assigned, encumbered or otherwise transferred, except, in the event of the
death of the Optionee, by will or by the laws of descent and
distribution.
 
 g.  Any
notice to the Company, including notice of exercise of an Option, shall be
addressed to the Company in care of Slava Jarnitskii at the Company’s principal
offices.
 
 IN
WITNESS WHEREOF, this Option Agreement has been executed on behalf of the
Company by a duly authorized officer and by the Optionee effective as of the
date of grant of the Option.


GENEREX BIOTECHNOLOGY
      CORPORATION
    
    
    ACCEPTED AND AGREED:By:
    /s/ Rose C. Perri
    
    
    /s/
      Mark FletcherROSE C. PERRI
    
    
    Mark
Fletcher